Cme (CME) Asset Writedowns and Impairment (2016 - 2021)

Cme (CME) has reported Asset Writedowns and Impairment for 5 consecutive years, with -$600000.0 the latest figure, recorded in Q4 2021.

• Quarterly Asset Writedowns and Impairment rose 45.45% year-over-year to -$600000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2021 was -$500000.0 (down 101.82% YoY) and the FY2020 annual result came in at $26.3 million, down 56.96% from the prior year.
• Asset Writedowns and Impairment eased to -$600000.0 in Q4 2021 per CME's latest filing, from $100000.0 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for CME reached as high as $39.5 million in Q3 2019 and fell as low as -$9.5 million in Q4 2018.
• A 4-year average of $7.9 million and a median of $500000.0 in 2021 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2019 — Asset Writedowns and Impairment surged 315.79% — and 2020, when it sank 101.27%.
• Year by year, Asset Writedowns and Impairment stood at -$9.5 million in 2018, then soared by 515.79% to $39.5 million in 2019, then slumped by 102.78% to -$1.1 million in 2020, then jumped by 45.45% to -$600000.0 in 2021.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$600000.0, $100000.0, and $500000.0 for Q4 2021, Q3 2021, and Q1 2021 respectively.